The U.S. is seeking to further expand soybean sales to China despite strong existing growth in shipments. China's approval process for new biotech products is slow, and public opposition to GMOs remains strong.
A 100-day trade action plan includes a China review of eight pending U.S. biotech applications, two of them for soybean products.
Faster Chinese approval of GMO soybean traits would support export demand for U.S. beans, while continued delays keep a regulatory risk premium on the trade.
Tras 696 eventos alcista de comercio pasados, Soja se movió una mediana de +0,3 % en 5 sesiones (54% al alza; mitad central entre -1,3 % y +1,9 %), y +0,7 % en 20.
Variaciones de la referencia de cada materia prima desde el último cierre antes del evento. Las lecturas históricas agrupan eventos pasados del mismo tipo; describen lo ocurrido, no lo que ocurrirá. No es asesoramiento de inversión.